EPCAM and retinoblastoma: Recently, we demonstrated an EpCAM antibody-based targeted approach for enhanced drug delivery to EpCAM-expressing retinoblastoma (RB) Y79 cells using EpCAM antibody conjugated polymeric nanoparticles loaded with chemotherapy drugs [34].